Raj Manchanda
Hoofd Techniek/Wetenschap/O&O bij NEUMORA THERAPEUTICS, INC.
Actieve functies van Raj Manchanda
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2023 | - |
Loopbaan van Raj Manchanda
Eerdere bekende functies van Raj Manchanda
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Anokion US, Inc. | Corporate Officer/Principal | 01-05-2019 | 01-07-2023 |
| KORRO BIO, INC. | Corporate Officer/Principal | 01-02-2016 | 01-10-2018 |
Opleiding van Raj Manchanda
| Yale University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Anokion US, Inc. | |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
- Beurs
- Insiders
- Raj Manchanda
- Ervaring
